companydata.dkMINERVAX ApS: Financial statements 2012
CVR: 32673287
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -1,060,392 and a net result of DKK -845,708. Equity amounted to DKK 1,427,220. The solvency ratio was 85.2%.
- Gross Profit
- -1,060,392 kr.
- Profit/Loss
- -845,708 kr.
- Equity
- 1,427,220 kr.
- Total Assets
- 1,674,958 kr.
How creditworthy is MINERVAX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of January 1, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of MINERVAX ApS.
As of January 1, 2012, VERAX has stepped down as auditor of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees. In 2025, the company reported a net result of DKK -31,530,000 compared with DKK -29,126,000 the year before. Equity amounted to DKK 9,787,000.